Logo image of SMCRT.OL

SMARTCRAFT ASA (SMCRT.OL) Stock Fundamental Analysis

OSL:SMCRT - Euronext Oslo - NO0011008971 - Common Stock - Currency: NOK

28.2  -0.4 (-1.4%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to SMCRT. SMCRT was compared to 101 industry peers in the Software industry. SMCRT has an excellent profitability rating, but there are some minor concerns on its financial health. SMCRT is growing strongly while it is still valued neutral. This is a good combination! These ratings could make SMCRT a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

In the past year SMCRT was profitable.
SMCRT had a positive operating cash flow in the past year.
SMCRT had positive earnings in each of the past 5 years.
Each year in the past 5 years SMCRT had a positive operating cash flow.
SMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFSMCRT.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

SMCRT has a better Return On Assets (7.53%) than 77.23% of its industry peers.
The Return On Equity of SMCRT (10.48%) is better than 65.35% of its industry peers.
With a decent Return On Invested Capital value of 9.69%, SMCRT is doing good in the industry, outperforming 79.21% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SMCRT is in line with the industry average of 10.36%.
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROIC 9.69%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
SMCRT.OL Yearly ROA, ROE, ROICSMCRT.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

The Profit Margin of SMCRT (18.01%) is better than 82.18% of its industry peers.
In the last couple of years the Profit Margin of SMCRT has grown nicely.
SMCRT's Operating Margin of 23.10% is amongst the best of the industry. SMCRT outperforms 87.13% of its industry peers.
In the last couple of years the Operating Margin of SMCRT has remained more or less at the same level.
SMCRT's Gross Margin of 91.34% is amongst the best of the industry. SMCRT outperforms 94.06% of its industry peers.
In the last couple of years the Gross Margin of SMCRT has remained more or less at the same level.
Industry RankSector Rank
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
SMCRT.OL Yearly Profit, Operating, Gross MarginsSMCRT.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SMCRT is still creating some value.
Compared to 1 year ago, SMCRT has less shares outstanding
SMCRT has about the same amout of shares outstanding than it did 5 years ago.
Compared to 1 year ago, SMCRT has a worse debt to assets ratio.
SMCRT.OL Yearly Shares OutstandingSMCRT.OL Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
SMCRT.OL Yearly Total Debt VS Total AssetsSMCRT.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 9.00 indicates that SMCRT is not in any danger for bankruptcy at the moment.
SMCRT's Altman-Z score of 9.00 is amongst the best of the industry. SMCRT outperforms 86.14% of its industry peers.
SMCRT has a debt to FCF ratio of 0.34. This is a very positive value and a sign of high solvency as it would only need 0.34 years to pay back of all of its debts.
SMCRT has a better Debt to FCF ratio (0.34) than 90.10% of its industry peers.
A Debt/Equity ratio of 0.02 indicates that SMCRT is not too dependend on debt financing.
SMCRT's Debt to Equity ratio of 0.02 is amongst the best of the industry. SMCRT outperforms 87.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Altman-Z 9
ROIC/WACC1.06
WACC9.1%
SMCRT.OL Yearly LT Debt VS Equity VS FCFSMCRT.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 0.82 indicates that SMCRT may have some problems paying its short term obligations.
SMCRT's Current ratio of 0.82 is on the low side compared to the rest of the industry. SMCRT is outperformed by 72.28% of its industry peers.
A Quick Ratio of 0.82 indicates that SMCRT may have some problems paying its short term obligations.
SMCRT has a worse Quick ratio (0.82) than 70.30% of its industry peers.
Industry RankSector Rank
Current Ratio 0.82
Quick Ratio 0.82
SMCRT.OL Yearly Current Assets VS Current LiabilitesSMCRT.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

8

3. Growth

3.1 Past

The earnings per share for SMCRT have decreased strongly by -13.14% in the last year.
The Earnings Per Share has been growing by 30.82% on average over the past years. This is a very strong growth
SMCRT shows a strong growth in Revenue. In the last year, the Revenue has grown by 28.95%.
SMCRT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 27.15% yearly.
EPS 1Y (TTM)-13.14%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-31.58%
Revenue 1Y (TTM)28.95%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%24.8%

3.2 Future

SMCRT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 21.94% yearly.
The Revenue is expected to grow by 13.00% on average over the next years. This is quite good.
EPS Next Y16.16%
EPS Next 2Y20.77%
EPS Next 3Y21.94%
EPS Next 5YN/A
Revenue Next Year12.69%
Revenue Next 2Y12.23%
Revenue Next 3Y13%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SMCRT.OL Yearly Revenue VS EstimatesSMCRT.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
SMCRT.OL Yearly EPS VS EstimatesSMCRT.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 46.23, the valuation of SMCRT can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of SMCRT indicates a somewhat cheap valuation: SMCRT is cheaper than 61.39% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of SMCRT to the average of the S&P500 Index (28.04), we can say SMCRT is valued expensively.
Based on the Price/Forward Earnings ratio of 28.94, the valuation of SMCRT can be described as expensive.
64.36% of the companies in the same industry are more expensive than SMCRT, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 37.64. SMCRT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 46.23
Fwd PE 28.94
SMCRT.OL Price Earnings VS Forward Price EarningsSMCRT.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, SMCRT is valued a bit cheaper than the industry average as 60.40% of the companies are valued more expensively.
SMCRT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SMCRT is cheaper than 62.38% of the companies in the same industry.
Industry RankSector Rank
P/FCF 45.59
EV/EBITDA 22.44
SMCRT.OL Per share dataSMCRT.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3 4 5

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates SMCRT does not grow enough to justify the current Price/Earnings ratio.
SMCRT has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as SMCRT's earnings are expected to grow with 21.94% in the coming years.
PEG (NY)2.86
PEG (5Y)1.5
EPS Next 2Y20.77%
EPS Next 3Y21.94%

0

5. Dividend

5.1 Amount

No dividends for SMCRT!.
Industry RankSector Rank
Dividend Yield N/A

SMARTCRAFT ASA

OSL:SMCRT (7/25/2025, 7:00:00 PM)

28.2

-0.4 (-1.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)05-07 2025-05-07/bmo
Earnings (Next)08-26 2025-08-26
Inst Owners40.99%
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner ChangeN/A
Market Cap4.84B
Analysts82.86
Price Target32.42 (14.96%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-20.93%
Min EPS beat(2)-22.72%
Max EPS beat(2)-19.14%
EPS beat(4)0
Avg EPS beat(4)-18.48%
Min EPS beat(4)-22.72%
Max EPS beat(4)-10.07%
EPS beat(8)1
Avg EPS beat(8)-5.84%
EPS beat(12)3
Avg EPS beat(12)-4.62%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.84%
Min Revenue beat(2)-6.15%
Max Revenue beat(2)-5.52%
Revenue beat(4)0
Avg Revenue beat(4)-4.65%
Min Revenue beat(4)-6.79%
Max Revenue beat(4)-0.13%
Revenue beat(8)0
Avg Revenue beat(8)-3.67%
Revenue beat(12)1
Avg Revenue beat(12)-3.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.55%
EPS NQ rev (1m)-6.25%
EPS NQ rev (3m)-15.1%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-0.47%
Revenue NQ rev (3m)-1.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.53%
Valuation
Industry RankSector Rank
PE 46.23
Fwd PE 28.94
P/S 8.99
P/FCF 45.59
P/OCF 30.27
P/B 5.23
P/tB N/A
EV/EBITDA 22.44
EPS(TTM)0.61
EY2.16%
EPS(NY)0.97
Fwd EY3.46%
FCF(TTM)0.62
FCFY2.19%
OCF(TTM)0.93
OCFY3.3%
SpS3.14
BVpS5.39
TBVpS-0.59
PEG (NY)2.86
PEG (5Y)1.5
Profitability
Industry RankSector Rank
ROA 7.53%
ROE 10.48%
ROCE 12.24%
ROIC 9.69%
ROICexc 11.4%
ROICexgc N/A
OM 23.1%
PM (TTM) 18.01%
GM 91.34%
FCFM 19.72%
ROA(3y)8.35%
ROA(5y)6.97%
ROE(3y)11.09%
ROE(5y)10.12%
ROIC(3y)11.14%
ROIC(5y)10.01%
ROICexc(3y)13.91%
ROICexc(5y)12.37%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)14.07%
ROCE(5y)12.65%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y12.62%
ROICexc growth 5Y9.01%
OM growth 3Y4.37%
OM growth 5Y0.76%
PM growth 3Y15.25%
PM growth 5Y2.97%
GM growth 3Y3.1%
GM growth 5Y0.76%
F-Score6
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.02
Debt/FCF 0.34
Debt/EBITDA 0.1
Cap/Depr 62.43%
Cap/Sales 9.98%
Interest Coverage 39.01
Cash Conversion 75.98%
Profit Quality 109.5%
Current Ratio 0.82
Quick Ratio 0.82
Altman-Z 9
F-Score6
WACC9.1%
ROIC/WACC1.06
Cap/Depr(3y)89.02%
Cap/Depr(5y)87.97%
Cap/Sales(3y)9.14%
Cap/Sales(5y)8.43%
Profit Quality(3y)114.47%
Profit Quality(5y)158.42%
High Growth Momentum
Growth
EPS 1Y (TTM)-13.14%
EPS 3Y38.9%
EPS 5Y30.82%
EPS Q2Q%-31.58%
EPS Next Y16.16%
EPS Next 2Y20.77%
EPS Next 3Y21.94%
EPS Next 5YN/A
Revenue 1Y (TTM)28.95%
Revenue growth 3Y23.56%
Revenue growth 5Y27.15%
Sales Q2Q%24.8%
Revenue Next Year12.69%
Revenue Next 2Y12.23%
Revenue Next 3Y13%
Revenue Next 5YN/A
EBIT growth 1Y-6.86%
EBIT growth 3Y28.96%
EBIT growth 5Y28.12%
EBIT Next Year50.64%
EBIT Next 3Y29.8%
EBIT Next 5YN/A
FCF growth 1Y5.25%
FCF growth 3Y14.53%
FCF growth 5Y29.46%
OCF growth 1Y22.78%
OCF growth 3Y18.89%
OCF growth 5Y30.95%